Findings do not support the contention that patients undergoing cardiac catheterization should have their beta blockers or ACE inhibitors suspended.
Researchers demonstrated that left ventricular unloading with transcatheter aortic valve replacement is associated with acute improvements in right ventricular function and right ventricular-pulmonary artery coupling.
Subcutaneous implantable cardioverter-defibrillator is a feasible option not only in patients without structural but also in a selected patient collective with structural heart disease.
The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.
Three-dimensional transesophageal echocardiography does not require contrast media, which may be particularly beneficial in patients with impaired renal function.
Endocardial left atrial appendage closure performed at high volume centers had the lowest in-hospital complications and 30-day readmissions, but with higher hospitalization costs.
This study adds to the understanding of the early complications associated with cardiovascular implantable electronic devices (CIEDs) and the institutional variability in the quality of CIED implantation.
A systematic review compared the safety and efficacy of prasugrel and ticagrelor in patients with ACS undergoing PCI.
Having atrial fibrillation, using home oxygen, having severe lung disease, or having a permanent pacemaker were predictive of lower health status after transcatheter mitral valve repair.
While wearable technology can provide substantial patient benefit, these devices carry significant privacy and security risks.